A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
PHASE4CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
April 30, 2003
Primary Completion Date
September 30, 2006
Study Completion Date
February 28, 2007
Conditions
Bipolar Disorder
Interventions
DRUG
Galantamine
DRUG
Placebos
Trial Locations (1)
02139
Cambridge Health Alliance, Cambridge
All Listed Sponsors
collaborator
Northwestern University
OTHER
lead
Cambridge Health Alliance
OTHER
NCT00195845 - A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder | Biotech Hunter | Biotech Hunter